ESPR Earnings Esperion Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -0.10 | 2026-05-08 | 10-Q |
| FY 2025 | 2025-12-31 | -0.11 | 2026-03-10 | 10-K |
| Q3 2025 | 2025-09-30 | -0.43 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.27 | 2025-08-13 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.21 | 2026-05-08 | 10-Q |
| FY 2025 | 2024-12-31 | -0.28 | 2026-03-10 | 10-K |
| Q3 2025 | 2024-09-30 | -0.17 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.01 | 2025-08-13 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.34 | 2025-05-08 | 10-Q |
| FY 2025 | 2023-12-31 | -2.03 | 2026-03-10 | 10-K |
| Q3 2024 | 2023-09-30 | -1.53 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.19 | 2024-08-12 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.79 | 2024-05-07 | 10-Q |
| FY 2024 | 2022-12-31 | -3.52 | 2025-03-07 | 10-K |
| Q3 2023 | 2022-09-30 | -2.78 | 2023-11-07 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.98 | 2023-08-01 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.93 | 2023-05-09 | 10-Q |
| FY 2022 | 2021-12-31 | -9.31 | 2023-02-21 | 10-K |
| Q3 2022 | 2021-09-30 | -7.78 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | -5.16 | 2022-08-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.